We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novanta
NOVT
$6.29B
| $55.9M | 0.1% |
351,094
+2,811
| +0.8% | +$432K |
|
102
Xencor
XNCR
$1.55B
| $54.3M | 0.09% |
1,947,669
+4,218
| +0.2% | +$130K |
|
103
MSCI
MSCI
$40.9B
| $53.8M | 0.09% |
96,211
-7,206
| -7% | -$3.81M |
|
104
Driven Brands
DRVN
$2.2B
| $53.4M | 0.09% |
1,761,418
+8,105
| +0.5% | +$229K |
|
105
McGrath RentCorp
MGRC
$2.92B
| $53.1M | 0.09% |
568,700
+13,292
| +2% | +$1.31M |
|
106
Noble Corp
NE
$6.51B
| $52.8M | 0.09% |
+1,338,515
| New | +$53.6M |
|
107
CRISPR Therapeutics
CRSP
$5.17B
| $52.3M | 0.09% |
1,156,810
-31,511
| -3% | -$1.53M |
|
108
PJT Partners
PJT
$4.38B
| $51.8M | 0.09% |
718,066
+5,919
| +0.8% | +$454K |
|
109
Applied Industrial Technologies
AIT
$13.3B
| $51.5M | 0.09% |
362,612
+2,988
| +0.8% | +$405K |
|
110
BJs Wholesale Club
BJ
$12.3B
| $50.9M | 0.09% |
669,448
-3,145
| -0.5% | -$228K |
|
111
WEX
WEX
$6.31B
| $50.9M | 0.09% |
276,579
-7,978
| -3% | -$1.45M |
|
|
AXON
112
Axon Enterprise
AXON
$46.4B
| $50M | 0.09% |
222,239
-62,517
| -22% | -$12.4M |
|
113
The Ensign Group
ENSG
$10.7B
| $49.9M | 0.09% |
522,049
+4,299
| +0.8% | +$394K |
|
114
Veeva Systems
VEEV
$37.4B
| $48.1M | 0.08% |
261,917
-21,873
| -8% | -$3.73M |
|
115
HEICO Corp
HEI
$51.4B
| $48.1M | 0.08% |
281,385
-22,193
| -7% | -$3.74M |
|
116
Trip.com Group
TCOM
$29.1B
| $48M | 0.08% |
1,273,304
+8,260
| +0.7% | +$307K |
|
117
Cactus
WHD
$5.44B
| $47.3M | 0.08% |
1,146,196
+9,514
| +0.8% | +$460K |
|
118
Under Armour
UAA
$2.6B
| $46.4M | 0.08% |
4,886,714
-319,724
| -6% | -$3.32M |
|
119
e.l.f. Beauty
ELF
$5.81B
| $46.3M | 0.08% |
562,726
-136,921
| -20% | -$9.23M |
|
120
Deckers Outdoor
DECK
$13.3B
| $46.1M | 0.08% |
614,634
-2,706
| -0.4% | -$189K |
|
121
Baidu
BIDU
$37.2B
| $45.4M | 0.08% |
301,110
+2,152
| +0.7% | +$305K |
|
122
Tenable Holdings
TENB
$4.01B
| $44.1M | 0.08% |
928,499
+7,666
| +0.8% | +$325K |
|
123
Calix
CALX
$2.39B
| $44.1M | 0.08% |
822,247
+6,838
| +0.8% | +$373K |
|
124
Boot Barn
BOOT
$4.95B
| $43.7M | 0.08% |
569,692
+2,117
| +0.4% | +$162K |
|
125
Interparfums
IPAR
$3.94B
| $43.4M | 0.08% |
305,134
+2,485
| +0.8% | +$306K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.